H1ssF_3928 / National Institute of Allergy and Infectious Diseases - LARVOL DELTA

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Completed | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Active, not recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Aug 2025 ➔ Dec 2025 | Trial primary completion date: Aug 2025 ➔ Dec 2025

Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Active, not recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | N=30 ➔ 50

Enrollment change • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=30 | Active, not recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting ➔ Active, not recruiting | N=50 ➔ 30

Enrollment change • Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Aug 2024 ➔ Aug 2025 | Trial primary completion date: Mar 2024 ➔ Aug 2025

Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (clinicaltrials.gov) - P1 | N=50 | Not yet recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

New P1 trial • Infectious Disease • Influenza • Respiratory Diseases